Global X Genomics & Biotechnology ETF (GNOM) Holdings $8.20 +0.01 (+0.06%) As of 01:46 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Holdings Stock AnalysisChartHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock Top 40 GNOM HoldingsRankCompanyCurrent PriceWeightShares Held1NTRANatera$158.36+1.1%6.93%22,0162QGENQiagen$42.99-0.3%5.22%60,2923VCYTVeracyte$31.50+3.8%5.13%80,4954BNTXBioNTech$101.94-2.9%4.97%23,5365BMRNBioMarin Pharmaceutical$61.99-0.1%4.80%37,3256ALNYAlnylam Pharmaceuticals$269.62+3.9%4.63%8,8587CRSPCRISPR Therapeutics$37.88-1.0%4.31%56,7838AAgilent Technologies$108.94+0.3%4.29%19,6449LEGNLegend Biotech$33.41+0.7%4.16%59,42510TECHBio-Techne$50.23-0.5%3.86%37,665 Get the Latest News and Ratings for GNOM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Global X Genomics & Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter. 11RNAAvidity Biosciences$32.13-0.2%3.76%57,52212Genscript Biotech CorporationN/A3.71%1,296,01813RAREUltragenyx Pharmaceutical$39.06-0.6%3.69%47,75214ARWRArrowhead Pharmaceuticals$14.12-2.1%3.59%131,09915BEAMBeam Therapeutics$19.95-1.5%3.55%88,60616GILDGilead Sciences$102.78-0.9%3.17%14,97217ILMNIllumina$78.64+1.0%2.86%18,26218VRTXVertex Pharmaceuticals$502.48+0.3%2.84%2,77719MRNAModerna$28.13+1.9%2.76%48,90420SRPTSarepta Therapeutics$64.00+0.8%2.48%20,10021CDNACareDx$15.20+1.3%2.25%61,00322TXG10x Genomics$8.47+0.5%2.09%123,04423NTLAIntellia Therapeutics$8.54-3.4%2.05%123,32924MYGNMyriad Genetics$7.72+2.1%1.58%107,91925QUREuniQure$15.77+6.8%1.56%55,55826RCKTRocket Pharmaceuticals$8.07+0.7%1.53%103,49627VIRVir Biotechnology$6.25+1.4%1.32%108,81228RGNXREGENXBIO$9.86-5.2%1.05%54,86529FLGTFulgent Genetics$20.05-2.4%0.90%24,36230VERVVerve Therapeutics$5.13-1.3%0.86%77,09731PACBPacific Biosciences of California$1.11-2.2%0.72%320,01832TSVT2seventy bio$5.01+0.1%0.62%61,13333MRVIMaravai LifeSciences$2.18+5.1%0.61%145,03334ALLOAllogene Therapeutics$1.65-3.2%0.55%174,32135SANASana Biotechnology$1.91+0.8%0.53%153,31136SGMOSangamo Therapeutics$0.72-0.7%0.36%245,92137EDITEditas Medicine$1.59-3.4%0.32%100,37638CRBUCaribou Biosciences$0.87-1.6%0.17%100,73039LYELLyell Immunopharma$0.45-2.9%0.15%167,94540CashN/A0.05%25,266Elon Reveals Why There Soon Won’t Be Any Money For Social Security (Ad)Elon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a terrifying supercar crash with billionaire Peter Thiel, then from a deadly strain of malaria—Elon Musk emerged with a stark warning for Americans about looming financial dangers. Discover the little-known Trump IRS loophole that thousands are now using to safeguard their retirement from inflation and market turmoil—before it's too late.See why thousands of forward-thinking retirement savers are now requesting this FREE 2025 Wealth Pro Geographic ExposureUnited States84.9%Netherlands5.2%Switzerland4.4%Cayman Islands3.8%Currency ExposureUSD75.9%HKD3.8%Sector ExposureHealth Care91.6%Materials5.2%Energy1.5%Industry ExposureBiotechnology57.1%Health Care Equipment & Supplies20.1%Health Care Providers & Services7.9%Life Sciences Tools & Services6.4%Metals & Mining5.2%Renewable Energy1.5%SubIndustry ExposureBiotechnology56.5%Life Sciences Tools & Services24.7%Health Care Services7.9%Diversified Metals & Mining5.2%Health Care Equipment1.8%Renewable Energy Equipment1.5% Related Companies and Tools Related Companies UFO Holdings FMED Holdings FDFF Holdings AOTG Holdings SPRX Holdings HECO Holdings SARK Holdings HRTS Holdings BLCN Holdings AGNG Holdings This page (NASDAQ:GNOM) was last updated on 5/5/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredU.S. Stock Market Now on Verge of CollapseThe last time the U.S. economy looked like this, stocks didn't move for 16 years... And many investors lost...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global X Genomics & Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Global X Genomics & Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
